Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed Patients
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
The possibility that hypersecretion of corticotropin-releasing factor (CRF) contributes to the hyperactivity of the hypothalamo-pituitary-adrenal axis observed in patients with major depression was investigated by measuring the concentration of this peptide in cerebrospinal fluid of normal healthy volunteers and in drug-free patients with DSM-III diagnoses of major depression, schizophrenia, or dementia. When compared to the controls and the other diagnostic groups, the patients with major depression showed significantly increased cerebrospinal fluid concentrations of CRF-like immunoreactivity; in 11 of the 23 depressed patients this immunoreactivity was greater than the highest value in the normal controls. These findings are concordant with the hypothesis that CRF hypersecretion is, at least in part, responsible for the hyperactivity of the hypothalamo-pituitary-adrenal axis characteristic of major depression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“HPA alterations correlate with impaired cognitive function 66,67 in depressed patients”
From Major depressive disorder (2016) · cites this paper as [67]
In the citing paper
“elevated basal cerebrospinal fluid CRH levels”
From Glucocorticoids, cytokines and brain abnormalities in depression (2011) · cites this paper as Nemeroff et al., 1984
Citations
Cites
Vale, W., Spiess, J., Rivier, C., & Rivier, J. (1981) · Science · doi:10.1126/science.6267699 · Cited by 3,965
Self-citationVALE, W., SPIESS, J., RIVIER, C., & RIVIER, J. (1982) · Obstetrical & Gynecological Survey · doi:10.1097/00006254-198205000-00013 · Cited by 3,904
Self-citationCarroll, B. J. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780260017001 · Cited by 2,243
Disrupted 24-hour patterns of cortisol secretion in psychotic depression
Sachar, E. J. (1973) · Archives of General Psychiatry · doi:10.1001/archpsyc.1973.01750310011002 · Cited by 775
Corticotropin-Releasing Factor: Actions on the Sympathetic Nervous System and Metabolism*
BROWN, M. R., FISHER, L. A., SPIESS, J., RIVIER, C., RIVIER, J., & VALE, W. (1982) · Endocrinology · doi:10.1210/endo-111-3-928 · Cited by 651
Self-citationNeuroendocrine Regulation in Depression: II. Discrimination of Depressed From Nondepressed Patients
Carroll, B. J. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770090041003 · Cited by 627
Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty
Britton, D. R., Koob, G. F., Rivier, J., & Vale, M. (1982) · Life Sciences · doi:10.1016/0024-3205(82)90416-7 · Cited by 534
Psychiatric implications of basic and clinical studies with corticotropin-releasing factor
(1984) · American Journal of Psychiatry · doi:10.1176/ajp.141.5.619 · Cited by 481
Corticotropin releasing factor (CRF): immunoreactive neurones and fibers in rat hypothalamus
Bloom, F. E., Battenberg, E. L. F., Rivier, J., & Vale, W. (1982) · Regulatory Peptides · doi:10.1016/0167-0115(82)90107-0 · Cited by 364
Self-citationGreden, J. F. (1983) · Archives of General Psychiatry · doi:10.1001/archpsyc.1983.01790050019002 · Cited by 358
Research works printed but not linked: 6
- Carroll, B. J., Handbook on Depression: 325 (1977).
- FISHMAN, A.J., PEPTIDES 1: 149 (1982).
- Rivier, J., Proceedings of the National Academy of Sciences of the United States of America 80: 4851 (1983).
- SNEDECOR, G.W., STAT METHODS: 271 (1967).
- SOKAL, R.R., BIOMETRY: 391 (1969).
- WHYBROW, P.C., MOOD DISORDERS NEW P: 1 (1984).
Cited by
Items 601–700 of 1,001
The stress response and autoimmunoregulation
Fricchione, G. L., & Stefano, G. B. (1994) · Advances in Neuroimmunology · doi:10.1016/s0960-5428(06)80187-7 · Cited by 63
Plasma dexamethasone concentrations and the dexamethasone suppression test
Ritchie, J., Belkin, B. M., Ranga, K., Krishnan, R. R., Nemeroff, C. B., & Bj, C. (1990) · Biological Psychiatry · doi:10.1016/0006-3223(90)90646-j · Cited by 61
Self-citationNeurobiology of Depression in Children and Adolescents
Zalsman, G., Oquendo, M. A., Greenhill, L., Goldberg, P. H., Kamali, M., Martin, A., & Mann, J. J. (2006) · Child and Adolescent Psychiatric Clinics of North America · doi:10.1016/j.chc.2006.05.010 · Cited by 62
Effects of chronic stress on anterior pituitary and brain corticotropin-releasing factor receptors
Anderson, S. M., Jean Kant, G., & De Souza, E. B. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90002-b · Cited by 57
Response to oCRH in depressed and nondepressed adolescents: does gender make a difference?
DORN, L. D., BURGESS, E. S., SUSMAN, E. J., von EYE, A., DeBELLIS, M. D., GOLD, P. W., & CHROUSOS, G. P. (1996) · Journal of the American Academy of Child & Adolescent Psychiatry · doi:10.1097/00004583-199606000-00016 · Cited by 56
Handa, R. J., Sharma, D., & Uht, R. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00065 · Cited by 50
“This dysregulation is characterized by increased cortisol secretory responses, enlarged adrenal gland volume (Rubin et al., 1987, 1996) and elevated CRH in cerebrospinal fluid (Nemeroff et al., 1984) in depressed patients.”
BackgroundLevant, B. (2013) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527311312040003 · Cited by 52
Sex differences in corticotropin releasing factor-evoked behavior and activated networks
Wiersielis, K., Wicks, B., Simko, H., Cohen, S. R., Khantsis, S., Baksh, N., Waxler, D. E., & Bangasser, D. A. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2016.07.007 · Cited by 61
“The epidemiology of trauma, PTSD, and other posttrauma disorders.”
BackgroundInfluentialJiang, Y., Peng, T., Gaur, U., Silva, M., Little, P. J., Chen, Z., Qiu, W., Zhang, Y., & Zheng, W. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00290 · Cited by 58
Worsening of Post-Traumatic Stress Disorder Symptoms with Cognitive Decline: Case Series
Mittal, D., Torres, R., Abashidze, A., & Jimerson, N. (2001) · Journal of Geriatric Psychiatry and Neurology · doi:10.1177/089198870101400105 · Cited by 55
CELLULAR MECHANISMS IN THE VULNERABILITY TO DEPRESSION AND RESPONSE TO ANTIDEPRESSANTS
Shelton, R. C. (2000) · Psychiatric Clinics of North America · doi:10.1016/s0193-953x(05)70193-3 · Cited by 60
Hauger, R. L., Irwin, M. R., Lorang, M. T., Aguilera, G., & Brown, M. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)90219-d · Cited by 57
Duncan, G. E., Little, K. Y., Kirkman, J. A., Kaldas, R. S., Stumpf, W. E., & Breese, G. R. (1992) · Brain Research · doi:10.1016/0006-8993(92)91699-f · Cited by 56
Melancholic Depression and the Hormones of Adversity: A Role for the Amygdala
Schulkin, J. A. (1994) · Current Directions in Psychological Science · doi:10.1111/1467-8721.ep10769930 · Cited by 55
Mom doesn’t care: When increased brain CRF system activity leads to maternal neglect in rodents
Klampfl, S. M., & Bosch, O. J. (2019) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2019.01.001 · Cited by 56
Iijima, M., Yoshimizu, T., Shimazaki, T., Tokugawa, K., Fukumoto, K., Kurosu, S., Kuwada, T., Sekiguchi, Y., & Chaki, S. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12699 · Cited by 55
“Patients with MDD also exhibit increased levels of CSF corticotropin-releasing factor (CRF) (Nemeroff et al., 1984), the primary hypothalamic factor driving stress-induced adrenocorticotropic hormone (ACTH) secretion from the anterior pituitary.”
BackgroundGe, J., Peng, L., Cheng, J., Pan, C., Tang, J., Chen, F., & Li, J. (2013) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2013.10.028 · Cited by 58
“…well documented in depression patients (Holsboer et al., 1984), with hypersecretion of cortisol, adrenocorticotropin (ACTH) (Nerozzi et al., 1988), and corticotropin-releasing hormone (CRH) (Nemeroff et al., 1984) or overexpression of CRH in the hypothalamus (Bao et al., 2005;Wang et al., 2008).”
BackgroundEmerging antidepressants to treat major depressive disorder
Block, S. G., & Nemeroff, C. B. (2014) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2014.09.001 · Cited by 63
“cerebrospinal fluid (CSF) (Nemeroff et al., 1984) much derived from extra-hypothalamic sources.”
BackgroundSelf-citationvan der Doelen, R. H. A., Arnoldussen, I. A., Ghareh, H., van Och, L., Homberg, J. R., & Kozicz, T. (2015) · Development and Psychopathology · doi:10.1017/s0954579414001345 · Cited by 53
“In addition, these patients display increased levels of CRF in their cerebrospinal fluid, which can be reduced by treatment with antidepressants or electroconvulsive shocks (Heuser et al., 1998, Nemeroff et al., 1984; Nemeroff, Bissette, Akil, & Fink, 1991).”
BackgroundDevelopment of CRF1 Receptor Antagonists as Antidepressants and Anxiolytics: Progress to Date
Valdez, G. R. (2006) · CNS Drugs · doi:10.2165/00023210-200620110-00002 · Cited by 58
Garza, R. D. L., Asnis, G. M., Pedrosa, E., Stearns, C., Migdal, A. L., Reinus, J. F., Paladugu, R., & Vemulapalli, S. (2005) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2005.03.008 · Cited by 62
Kozicz, T., Bordewin, L. A. P., Czéh, B., Fuchs, E., & Roubos, E. W. (2008) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2008.02.012 · Cited by 62
“A growing body of evidence links central CRF pathways with the development of depression (Nemeroff et al., 1984; Nemeroff, 1988; Plotsky et al., 1998; Arborelius et al., 1999; Reul and Holsboer, 2002).”
Weathington, J. M., Hamki, A., & Cooke, B. M. (2014) · Journal of Comparative Neurology · doi:10.1002/cne.23475 · Cited by 53
“Mood disorders are often accompanied by dysregulation of the hypothalamic–pituitary–adrenal (HPA) axis; elevated CRF in the cerebrospinal fluid of depressed patients was a seminal early finding (Nemeroff et al., 1984).”
BackgroundDinan, T. (2001) · Human Psychopharmacology: Clinical and Experimental · doi:10.1002/hup.188 · Cited by 54
Amsterdam, J. D., Maislin, G., Gold, P., & Winokur, A. (1989) · Psychoneuroendocrinology · doi:10.1016/0306-4530(89)90055-3 · Cited by 53
“, 1985), and elevated concentrations of CRF-like immunoreactivity have also been reported in the cerebrospinal fluid of some depressed patients (Nemeroff et al., 1984; Roy et al., 1987).”
BackgroundHypothalamo-pituitary-adrenal axis abnormalities in depression: a review and a model
Charlton, B. G., & Ferrier, I. N. (1989) · Psychological Medicine · doi:10.1017/s003329170001237x · Cited by 53
“While it has proved difficult, using present techniques, to find firm evidence for increased CRH levels in the hypophysial portal system; there are reports of elevated CRH concentrations in the cerebrospinal fluid of depressed patients (Nemeroff et al. 1984; Banki et al. 1987).”
BackgroundWong, M., WEBSTER, E. L., Spokes, H., Phu, P., Ehrhart‐Bornstein, M., Bornstein, S. R., Park, C. S., Rice, K. C., Chrousos, G. P., Licinio, J., et al. (1999) · Life Sciences · doi:10.1016/s0024-3205(99)00268-4 · Cited by 54
Don't leave the “psych” out of neuropsychology
Gray, J. A., & Baruch, I. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047579 · Cited by 56
Neuropeptides involved in the pathophysiology of schizophrenia and major depression
de Wied, D., & Sigling, H. O. (2002) · Neurotoxicity Research · doi:10.1080/10298420290031432 · Cited by 56
Do panic disorder and posttraumatic stress disorder share a common psychoneuroendocrinology?
Kellner, M. B., & Yehuda, R. (1999) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(99)00012-8 · Cited by 59
Spinal fluid CRF reduction in Alzheimer's disease
Mouradian, M. M., Farah, J. M., Mohr, E., Fabbrini, G., O’Donohue, T. L., & Chase, T. N. (1986) · Neuropeptides · doi:10.1016/0143-4179(86)90010-7 · Cited by 56
Schmidt, E. D., Schoffelmeer, A. N. M., De Vries, T. J., Wardeh, G., Dogterom, G., Bol, J. G. J. M., Binnekade, R., & Tilders, F. J. H. (2001) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01569.x · Cited by 52
“…seen following adrenalectomy, chronic stress (Plotsky & Sawchenko, 1987; Aguilera et al., 1992; De Goeij et al., 1992; Harbuz & Lightman, 1992; Bartanusz et al., 1993; Dallman, 1993; Whitnall, 1993; Aguilera, 1994; Shanks et al., 1998) and depression (Nemeroff et al., 1984; Tilders et al., 1999).”
Souza, E. B. D., & Kuhar, M. J. (1986) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/0076-6879(86)24040-9 · Cited by 53
Neuroendocrine Stress System in Bipolar Disorder
Juruena, M. F., Cleare, A. J., & Young, A. H. (2020) · Current topics in behavioral neurosciences · doi:10.1007/7854_2020_184 · Cited by 54
Finn, D. P., Martí, O., Harbuz, M. S., Vallès, A., Belda, X., Márquez, C., Jessop, D. S., Lalies, M. D., Armario, A., Nutt, D. J., et al. (2003) · Psychopharmacology · doi:10.1007/s00213-003-1392-3 · Cited by 60
“Hypothalamo-pituitaryadrenal (HPA) axis dysfunction is observed in depressed patients (Nemeroff et al. 1984; Halbreich et al. 1985; Arato et al. 1986; Holsboer et al. 1986; Modell et al. 1997).”
BackgroundChanges in the immune system in depression and dementia: causal or coincidental effects?
Leonard, B. E., & Myint, A. (2006) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2006.8.2/bleonard · Cited by 51
O’Connell, C. P., Goldstein‐Piekarski, A. N., Nemeroff, C. B., Schatzberg, A. F., DeBattista, C., Carrillo‐Roa, T., Binder, E. B., Dunlop, B. W., Craighead, W. E., Mayberg, H. S., et al. (2017) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2017.17020172 · Cited by 53
“Elevated CRH concentrations have been repeatedly reported both in the CSF of depressed individuals (Nemeroff et al., 1984; Banki et al., 1987) and suicide victims (Arató et al.”
Self-citationVythilingam, M. (2000) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.11.4138 · Cited by 51
“Studies in human subjects with mood and anxiety disorders have to a great extent relied upon cerebrospinal fluid (CSF) CRH concentrations as an index of central CRH function (6, 7, 36 ).”
BackgroundSelf-citationNeurobiological mechanisms in addictive and psychiatric disorders
Bruijnzeel, A. W., Repetto, M. J., & Gold, M. S. (2004) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2004.06.005 · Cited by 57
“Nemeroff et al [73] showed that CRF levels are increased in the cerebrospinal fluid (CSF) of patients with major depression compared with healthy controls and patients with either schizophrenia or dementia.”
BackgroundMaes, M., Vandervorst, C., Suy, E., Minner, B., & Raus, J. (1991) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1991.tb05580.x · Cited by 51
Pérez-Nievas, B. G., García-Bueno, B., Caso, J. R., Menchén, L., & Leza, J. C. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.04.011 · Cited by 51
“, 1983) urinary excretion, as well as higher CRF levels in CSF (Nemeroff et al., 1984) than control patients.”
BackgroundBenzodiazepines and anterior pituitary function
Arvat, E., Giordano, R., Grottoli, S., & Ghigo, E. (2002) · Journal of Endocrinological Investigation · doi:10.1007/bf03345110 · Cited by 51
Sleep deprivation therapy in depressive illness and parkinson's disease
DeMet, E. M., Chicz-DeMet, A., Fallon, J. H., & Sokolski, K. N. (1999) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/s0278-5846(99)00039-1 · Cited by 53
Rassnick, S., Sved, A., & Rabin, B. (1994) · The Journal of Neuroscience · doi:10.1523/jneurosci.14-10-06033.1994 · Cited by 50
“…et al., 1988; Melia and Duman, 199 l), or neuropsychiatric disorders that may be associated with a hypersection of CRH (Holsboer et al., 1984; Nemeroff et al., 1984; Gold et al., 1986) and CNS diseases that are associated with a depletion of locus coeruleus neurons (Tavalato and Argenteiro ,…”
BackgroundHyperresponsiveness of the rat neuroendocrine system due to repeated exposure to stress
Orr, T. E., Meyerhoff, J. L., Mougey, E. H., & Bunnell, B. N. (1990) · Psychoneuroendocrinology · doi:10.1016/0306-4530(90)90057-g · Cited by 54
Casello, S. M., Flores, R. J., Yarur, H. E., Wang, H., Awanyai, M., Arenivar, M. A., Jaime-Lara, R. B., Bravo-Rivera, H., & Tejeda, H. A. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2022.796443 · Cited by 54
Lyons, D. M., Wang, O. J., Lindley, S. E., Levine, S., Kalin, N. H., & Schatzberg, A. F. (1999) · Psychoneuroendocrinology · doi:10.1016/s0306-4530(98)00065-1 · Cited by 50
“These results, and reports of increased CRF-like immunoreactivity in cerebrospinal fluid (Kling et al., 1991; Nemeroff et al., 1984) suggest that excessive central stimulation by endogenous CRF is opposed at the pituitary by counter-regulatory feedback from chronic hypersecretion of cortisol in depression.”
BackgroundKim, S.-J., Park, S.-H., Choi, S.-H., Moon, B., Lee, K. J., Kang, S., Lee, M.-S., Choi, S.-H., Chun, B., & Shin, K.-H. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.12.003 · Cited by 54
Corticotropin-releasing factor type-1 receptor antagonists: The next class of antidepressants?
Nielsen, D. M. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.06.003 · Cited by 54
CSF corticotropin-releasing factor is not affected in panic disorder
Jolkkonen, J., Lepola, U., Bissette, G., Nemeroff, C., & Riekkinen, P. (1993) · Biological Psychiatry · doi:10.1016/0006-3223(93)90315-5 · Cited by 49
Self-citationWhat can post-mortem studies tell us about the pathoetiology of suicide?
Pandey, G. N., & Dwivedi, Y. (2010) · Future Neurology · doi:10.2217/fnl.10.49 · Cited by 51
“The evidence suggesting an abnormality of CRF in depression is derived from the observations of a blunted ACTH response to exogenous administration of CRF [159], increased levels of CRF in the CSF of depressed patients [140,160] and increased numbers of CRFimmunoreactive and CRF mRNA-containing PVNs in hypothalamic ne…”
BackgroundThe Role of Neuropeptides in Suicidal Behavior: A Systematic Review
Serafini, G., Pompili, M., Lindqvist, D., Dwivedi, Y., & Girardi, P. (2013) · BioMed Research International · doi:10.1155/2013/687575 · Cited by 49
“Further additional studies will elucidate the pathophysiological mechanisms of the different neuropeptides pathways underlying suicidal behavior.”
Walker, L. C., Cornish, L. C., Lawrence, A. J., & Campbell, E. J. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.09.037 · Cited by 52
Stress Adaptation and the Brainstem with Focus on Corticotropin-Releasing Hormone
Chaves, T., Fazekas, C. L., Horváth, K., Correia, P., Szabó, A., Török, B., Bánrévi, K., & Zelena, D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22169090 · Cited by 53
“Indeed, increased CRH content was found in the cerebrospinal fluid (CSF) of depressed patients [46].”
BackgroundDissecting the genetic effect of the CRH system on anxiety and stress-related behaviour
Deussing, J. M., & Wurst, W. (2005) · Comptes Rendus. Biologies · doi:10.1016/j.crvi.2005.01.001 · Cited by 49
The Social Structure, Stress, and Women's Health
WILLIAMS, K., & KURINA, L. M. (2002) · Clinical Obstetrics and Gynecology · doi:10.1097/00003081-200212000-00018 · Cited by 43
Coplan, J. D., Altemus, M., Mathew, S. J., Smith, E. L. P., Scharf, B., Coplan, P. M., Kral, J. G., Gorman, J. M., Owens, M. J., Nemeroff, C. B., et al. (2005) · CNS Spectrums · doi:10.1017/s109285290001018x · Cited by 49
“Assays for CRF were performed according to the methods described by Nemeroff and colleagues.(6) Data on maternal parity were not available.”
MethodSelf-citationModulation of the human glucocorticoid receptor function by antidepressive compounds
Okuyama-Tamura, M., Mikuni, M., & Kojima, I. (2003) · Neuroscience Letters · doi:10.1016/s0304-3940(03)00261-1 · Cited by 52
Corticotropin-releasing factor binding sites in cortex of depressed suicides
Hucks, D., Lowther, S., Crompton, M. R., Katona, C., & Horton, R. W. (1997) · Psychopharmacology · doi:10.1007/s002130050439 · Cited by 54
“In drug-free depressed patients, elevated concentrations of CRF within the cerebrospinal fluid (CSF) have been fairly consistently reported (Nemeroff et al. 1984; Banki et al. 1987; France et al. 1988; Arato et al. 1989).”
BackgroundRoy, A., Pickar, D., Linnoila, M., Chrousos, G. P., & Gold, P. W. (1987) · Psychiatry Research · doi:10.1016/0165-1781(87)90083-7 · Cited by 49
Young, E. A. (1990) · Archives of General Psychiatry · doi:10.1001/archpsyc.1990.01810170049008 · Cited by 49
Self-citationBehavioral epigenetics and the developmental origins of child mental health disorders
Lester, B. M., Marsit, C. J., Conradt, E., Bromer, C., & Padbury, J. F. (2012) · Journal of Developmental Origins of Health and Disease · doi:10.1017/s2040174412000426 · Cited by 48
Glaser, Y. G., Zubieta, J.-K., Hsu, D. T., Villafuerte, S., Mickey, B. J., Trucco, E. M., Burmeister, M., Zucker, R. A., & Heitzeg, M. M. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.3672-13.2014 · Cited by 48
“Hyperactivity of the CRH system in the hypothalamus and other brain regions has been implicated in anxiety and mood disorders (Nemeroff et al., 1984; Heuser et al., 1994; Arborelius et al., 1999; Wong et al., 2000; de Kloet et al., 2005; Berton and Nestler, 2006).”
BackgroundChronobiology of the Hypothalamic-Pituitary-Adrenal and Renin-Angiotensin-Aldosterone Systems
Angeli, A., Gatti, G., & Masera, R. G. (1992) · Springer eBooks · doi:10.1007/978-3-642-78734-8_22 · Cited by 50
Chen, Y. L., Braselton, J. P., Forman, J. T., Gallaschun, R. J., Mansbach, R. S., Schmidt, A. W., Seeger, T., Sprouse, J. S., Tingley, F. D., Winston, E., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070578k · Cited by 53
Corticotropin-releasing factor receptor-1: a therapeutic target for cardiac autonomic disturbances
Wood, S. K., & Woods, J. H. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.11.1401 · Cited by 47
“In conclusion, depressed individuals have been reported to exhibit elevated CRF in cerebrospinal fluid [101] .”
BackgroundReduced glucocorticoid receptors: consequence or cause of depression?
Neigh, G. N., & Nemeroff, C. B. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.03.002 · Cited by 57
“More specifically, elevations in corticotropin releasing factor (CRF) have been reported in depressed patients in both CSF and postmortem studies [14], and CRF receptor 2 knockout mice and CRF overexpressing transgenic mice demonstrate depression-like behaviors [15].”
BackgroundSelf-citationBeekman, M., Flachskamm, C., & Linthorst, A. C. E. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04107.x · Cited by 53
“and probably involve hyperactivity of the corticotropin-releasing hormone (CRH) system (Nemeroff et al., 1984; Raadsheer et al., 1994; Arborelius et al., 1999; Holsboer, 1999).”
BackgroundClow, A. (2002) · International review of neurobiology · doi:10.1016/s0074-7742(02)52012-2 · Cited by 48
Coplan, J. D., Fathy, H. M., Jackowski, A. P., Tang, C. Y., Perera, T. D., Mathew, S. J., Martinez, J., Abdallah, C. G., Dwork, A. J., Pantol, G., et al. (2014) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2014.00342 · Cited by 47
“Assays for CRF were performed according to the methods described in Nemeroff et al. (1984).”
MethodSelf-citationWood, S. (2014) · Current Neuropharmacology · doi:10.2174/1570159x11666131120224413 · Cited by 41
“Consistent with findings of increased CSF levels of CRF linked to major depression in humans [41] evidence of HPA axis hyperactivity and exaggerated CRF release was identified in the passive SL phenotype [22].”
Complex regulatory interactions control CRH gene expression
Nicholson, R. (2004) · Frontiers in Bioscience · doi:10.2741/1204 · Cited by 48
“Pathologically, CRH production in the CNS is increased in depression (11), and rheumatoid arthritis has been associated with polymorphisms of the CRH promoter (12) and CRH levels are increased in arthritis affected joints (13).”
BackgroundSexual behavior and wet dog shakes in the male rat: regulation by corticosterone
Gorzalka, B. B., & Hanson, L. A. (1998) · Behavioural Brain Research · doi:10.1016/s0166-4328(98)00035-7 · Cited by 47
Abnormalities of the HPA axis in affective disorders: clinical subtypes and potential treatments
Porter, R. J., & Gallagher, P. (2006) · Acta Neuropsychiatrica · doi:10.1111/j.1601-5215.2006.00152.x · Cited by 45
“(62) found a significantly greater CSF CRH concentration in depressed patients than in healthy volunteers and patients with schizophrenia or dementia.”
BackgroundKagamiishi, Y., Yamamoto, T., & Watanabe, S. (2003) · Brain Research · doi:10.1016/j.brainres.2003.08.021 · Cited by 54
Gilmor, M. L., Skelton, K. H., Nemeroff, C. B., & Owens, M. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.045419 · Cited by 53
“Patients with major depression (Nemeroff et al., 1984) and post-traumatic stress disorder (Bremner et al.”
BackgroundSelf-citationThe corticotropin-releasing hormone stimulation test in chronic schizophrenia
(1986) · American Journal of Psychiatry · doi:10.1176/ajp.143.11.1393 · Cited by 46
Large-scale analysis of glucocorticoid target genes in rat hypothalamus
Sato, H., Horikawa, Y., Iizuka, K., Sakurai, N., Tanaka, T., Shihara, N., Oshima, A., Takeda, J., & Mikuni, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05489.x · Cited by 46
Bangasser, D. A., & Kawasumi, Y. (2015) · Hormones and Behavior · doi:10.1016/j.yhbeh.2015.04.003 · Cited by 43
“…these disorders have alterations in stress circuitry (Hamilton et al., 2008; Karl et al., 2006; Kitayama et al., 2005), as well as dysregulated stress hormones and stress-related neuropeptides (Deuschle et al., 1997; Elzinga et al., 2003; Holsboer, 2001; Nemeroff et al., 1984; Yehuda et al., 2005).”
BackgroundFemale psychopharmacology matters! Towards a sex-specific psychopharmacology
Bolea-Alamanac, B. M., Bailey, S., Lovick, T. A., Scheele, D., & Valentino, R. J. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881117747578 · Cited by 48
Ohmura, Y., Izumi, T., Yamaguchi, T., Tsutsui‐Kimura, I., Yoshida, T., & Yoshioka, M. (2010) · Neuropsychopharmacology · doi:10.1038/npp.2009.229 · Cited by 53
“Moreover, several psychiatric disorders, such as major depression (Nemeroff et al., 1984) and posttraumatic stress disorder (Baker et al.”
Nappi, R. E., Petraglia, F., Genazzani, A. D., D’Ambrogio, G., Zara, C., & Genazzani, A. R. (1993) · Fertility and Sterility · doi:10.1016/s0015-0282(16)55802-6 · Cited by 49
Depression really does hurt your heart: stress, depression, and cardiovascular disease
Musselman, D. L., & Nemeroff, C. B. (2000) · Progress in brain research · doi:10.1016/s0079-6123(08)62130-5 · Cited by 50
Self-citationMamalakis, G., Kiriakakis, M., Tsibinos, G., & Kafatos, A. (2004) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.10.005 · Cited by 54
Corticotropin-releasing factor activates the noradrenergic neuron system in the rat brain
Emoto, H., Tanaka, M., Koga, C., Yokoo, H., Tsuda, A., & Yoshida, M. (1993) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(93)90259-v · Cited by 46
Maes, M. H. J., Minner, B., Suy, E., Vandervorst, C., & Raus, J. (1991) · Journal of Neural Transmission · doi:10.1007/bf01244945 · Cited by 46
“, 1988) whilst melancholia is characterized by increased cerebrospinal fluid levels of CRH (Nemeroff et al., 1984; Banki et al., 1987).”
BackgroundThe role of tumor necrosis factor-alpha in stress-induced worsening of cerebral ischemia in rats
Caso, J. R., Lizasoain, I., Lorenzo, P., Moro, M. A., & Leza, J. C. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.06.009 · Cited by 45
Kling, M. A., DeBellis, M. D., O'Rourke, D. K., Listwak, S. J., Geracioti, T. D., McCutcheon, I. E., Kalogeras, K. T., Oldfield, E. H., & Gold, P. W. (1994) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.79.1.8027234 · Cited by 45
Ward, M. P. (2010) · Frontiers in Neuroengineering · doi:10.3389/fneng.2010.00007 · Cited by 43
“Observations leading to and strengthening this theory are: (1) elevated CRH and cortisol levels were observed in the cerebrospinal fluid (Nemeroff et al., 1984; Merali et al., 2004) and plasma (Burke et al., 2005) of depressed patients, respectively; (2) higher levels of cortisol and ACTH…”
Neuroanatomical and Neuropsychological Features of Euthymic Patients with Bipolar Disorder
Delaloye, C., de Bilbao, F., Moy, G., Baudois, S., Weber, K., Campos, L., Canuto, A., Giardini, U., von Gunten, A., Stancu, R., et al. (2009) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181b7f0e2 · Cited by 47
Wang, L. A., de Kloet, A. D., Smeltzer, M. D., Cahill, K. M., Hiller, H., Bruce, E. B., Pioquinto, D. J., Ludin, J. A., Katovich, M. J., Raizada, M. K., et al. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2018.01.025 · Cited by 45
Choi, K. W., Na, E. J., Fava, M., Mischoulon, D., Cho, H., & Jeon, H. J. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.09.047 · Cited by 47
Steine, I. M., LeWinn, K. Z., Lisha, N. E., Tylavsky, F. A., Smith, R., Bowman, M. E., Sathyanarayana, S., Karr, C. J., Smith, A. K., Kobor, M. S., et al. (2020) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113461 · Cited by 46
“In humans, exposure to CTE or a broader range of childhood adversities strongly predict developing PTSD and depression (Hughes et al., 2017), both of which have been linked to higher CRH levels in the brain (Bremner et al., 1997; Nemeroff et al., 1984).”
BackgroundPostmortem and Cerebrospinal Fluid Studies of Corticotropin‐releasing Factor in Humansa
HARTLINE, K. M., Owens, M. J., & Nemeroff, C. B. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb15114.x · Cited by 47
Self-citationRole of bombesin-related peptides in the mediation or integration of the stress response
Merali, Z., Kent, P., & Anisman, H. (2002) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-002-8422-x · Cited by 51
von Bardeleben, U., & Holsboer, F. (1988) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/0278-5846(88)90079-6 · Cited by 49
Visser, J., Lentjes, E., Haspels, I., Graffelman, W., Blauw, B., de Kloet, R., & Nagelkerken, L. (2001) · Journal of Investigative Medicine · doi:10.2310/6650.2001.34047 · Cited by 45
Peeters, B. W. M. M., & Broekkamp, C. L. E. (1994) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/0960-0760(94)90288-7 · Cited by 49
Ottowitz, W. E. (2004) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.16.4.446 · Cited by 45
Russig, H., Pezze, M. A., Bahr, N. I., Pryce, C. R., Feldon, J., & Murphy, C. A. (2003) · Behavioural Pharmacology · doi:10.1097/00008877-200302000-00001 · Cited by 49
“Finally, dysregulation of the hypothalamic–pituitary– adrenal (HPA) axis has been reported in both schizophrenic and depressed patients (Nemeroff et al., 1984; Rubin et al., 1987; Breier, 1989; Tandon et al., 1991; Kudoh et al., 1997; Jansen et al., 1998, 2000; Holsboer, 2000).”
Background
Metadata
- Authors
- Nemeroff, C. B., Widerlöv, E., Bissette, G., Walléus, H., Karlsson, I., Eklund, K., Kilts, C. D., Loosen, P. T., & Vale, W.
- Affiliations
- Duke University (US)
- Uppsala University (SE)
- Duke Medical Center (US)
- University of Gothenburg (SE)
- Salk Institute for Biological Studies (US)
- Venue
- Science
- Published
- 1984-12-14
- Volume
- 226
- Issue
- 4680
- Pages
- 1342-1344
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W1974253960
- Semantic Scholar
- 1a0f9dda77d66396db9247777d53158b0628b325
- Cited by
- 1,485
- References
- 29
- Citations by year
- 2026: 6 · 2025: 9 · 2024: 16 · 2023: 16 · 2022: 14 · 2021: 20 · 2020: 26 · 2019: 27 · 2018: 21 · 2017: 34 · 2016: 36 · 2015: 34 · 2014: 46 · 2013: 39 · 2012: 37
- FWCI
- 12.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Neuroendocrine regulation and behavior
- Keywords
- corticotropin-releasing factor, cerebrospinal fluid, major depressive disorder, hypothalamic-pituitary-adrenal axis, hypersecretion, schizophrenia, dementia
- MeSH terms
- Adult, Aged, Corticotropin-Releasing Hormone, Dementia, Depressive Disorder, Female, Humans, Male, Middle Aged, Radioimmunoassay, Schizophrenia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.